Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors.

Elhalawani H, Awan MJ, Ding Y, Mohamed ASR, Elsayes AK, Abu-Gheida I, Wang J, Hazle J, Gunn GB, Lai SY, Frank SJ, Ginsberg LE, Rosenthal DI, Fuller CD.

Sci Data. 2020 Feb 21;7(1):63. doi: 10.1038/s41597-020-0392-z.

PMID:
32081849
2.

An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer.

Nantavithya C, Gomez DR, Chang JY, Mohamed ASR, Fuller CD, Li H, Brooks ED, Gandhi SJ.

Radiother Oncol. 2020 Feb 13;145:209-214. doi: 10.1016/j.radonc.2020.01.002. [Epub ahead of print]

3.

Automatic registration of 2D MR cine images for swallowing motion estimation.

Yang J, Mohamed ASR, Bahig H, Ding Y, Wang J, Ng SP, Lai S, Miller A, Hutcheson KA, Fuller CD; Joint Head and Neck Radiotherapy MRI Development Cooperative.

PLoS One. 2020 Feb 11;15(2):e0228652. doi: 10.1371/journal.pone.0228652. eCollection 2020.

4.

Real-world applications of deep convolutional neural networks in diagnostic cancer imaging.

Elhalawani H, Yang P, Abazeed M, Shah C, Mohamed ASR, Thomas CR Jr, Fuller CD, Thompson RF.

Chin Clin Oncol. 2020 Feb 1. pii: cco.2020.01.02. doi: 10.21037/cco.2020.01.02. [Epub ahead of print] No abstract available.

5.

CD8 infiltration is associated with disease control and tobacco exposure in intermediate-risk oropharyngeal cancer.

Kemnade JO, Elhalawani H, Castro P, Yu J, Lai S, Ittmann M, Mohamed ASR, Lai SY, Fuller CD, Sikora AG, Sandulache VC.

Sci Rep. 2020 Jan 14;10(1):243. doi: 10.1038/s41598-019-57111-5.

6.

Lymphopenia during radiotherapy in patients with oropharyngeal cancer.

Ng SP, Bahig H, Jethanandani A, Pollard C, Berends J, Sturgis EM, Johnson FM, Elgohari B, Elhalawani H, Rosenthal DI, Skinner HD, Gunn GB, Phan J, Frank SJ, Mohamed ASR, Fuller CD, Garden AS.

Radiother Oncol. 2020 Jan 10;145:95-100. doi: 10.1016/j.radonc.2019.12.023. [Epub ahead of print]

PMID:
31931292
7.

Exclusion of Patients with Brain Metastases from Cancer Clinical Trials.

Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB.

Neuro Oncol. 2020 Jan 4. pii: noz246. doi: 10.1093/neuonc/noz246. [Epub ahead of print] No abstract available.

PMID:
31900480
8.

Stability analysis of CT radiomic features with respect to segmentation variation in oropharyngeal cancer.

Liu R, Elhalawani H, Radwan Mohamed AS, Elgohari B, Court L, Zhu H, Fuller CD.

Clin Transl Radiat Oncol. 2019 Nov 28;21:11-18. doi: 10.1016/j.ctro.2019.11.005. eCollection 2020 Mar.

9.

A prospective evaluation of health-related quality of life after skull base re-irradiation.

Bahig H, Ng SP, Pollard C 3rd, Nguyen TP, Gunn GB, Rosenthal DI, Fuller CD, Frank SJ, Garden AS, Reddy JP, Morrison WH, Ferrarotto R, Hanna EY, DeMonte F, Su SY, Phan J.

Head Neck. 2020 Mar;42(3):485-497. doi: 10.1002/hed.26037. Epub 2019 Dec 23.

PMID:
31868271
10.

In Regard to Wallner et al.

Kang J, Thompson RF, Fuller CD, Camphausen KA, Gabriel PE, Thomas CR.

Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):217-218. doi: 10.1016/j.ijrobp.2019.10.044. No abstract available.

PMID:
31836083
11.

MRIgRT head and neck anthropomorphic QA phantom: Design, development, reproducibility, and feasibility study.

Steinmann A, Alvarez P, Lee H, Court L, Stafford R, Sawakuchi G, Wen Z, Fuller CD, Followill D.

Med Phys. 2020 Feb;47(2):604-613. doi: 10.1002/mp.13951. Epub 2020 Jan 7.

PMID:
31808949
12.

Quantifying the benefit of non-small-cell lung cancer immunotherapy.

Ludmir EB, McCaw ZR, Grossberg AJ, Wei LJ, Fuller CD.

Lancet. 2019 Nov 23;394(10212):1904. doi: 10.1016/S0140-6736(19)32503-6. No abstract available.

PMID:
31777387
13.

Imaging for Response Assessment in Radiation Oncology: Current and Emerging Techniques.

Stieb S, Kiser K, van Dijk L, Livingstone NR, Elhalawani H, Elgohari B, McDonald B, Ventura J, Mohamed ASR, Fuller CD.

Hematol Oncol Clin North Am. 2020 Feb;34(1):293-306. doi: 10.1016/j.hoc.2019.09.010. Epub 2019 Oct 31. Review.

PMID:
31739950
14.

Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model.

Ng SP, Ajayi T, Schaefer AJ, Pollard C 3rd, Bahig H, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Phan J, Morrison WH, Johnson JM, Mohamed ASR, Sturgis EM, Fuller CD.

Cancer. 2020 Feb 15;126(4):749-756. doi: 10.1002/cncr.32597. Epub 2019 Nov 14.

PMID:
31725906
15.

Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials.

Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas CR Jr, Fuller CD, VanderWalde NA.

J Geriatr Oncol. 2019 Nov 8. pii: S1879-4068(19)30348-0. doi: 10.1016/j.jgo.2019.11.001. [Epub ahead of print]

PMID:
31711757
16.

Imaging for Target Delineation and Treatment Planning in Radiation Oncology: Current and Emerging Techniques.

Stieb S, McDonald B, Gronberg M, Engeseth GM, He R, Fuller CD.

Hematol Oncol Clin North Am. 2019 Dec;33(6):963-975. doi: 10.1016/j.hoc.2019.08.008. Epub 2019 Sep 17. Review.

PMID:
31668214
17.

"Après Mois, Le Déluge": Preparing for the Coming Data Flood in the MRI-Guided Radiotherapy Era.

Kiser KJ, Smith BD, Wang J, Fuller CD.

Front Oncol. 2019 Sep 30;9:983. doi: 10.3389/fonc.2019.00983. eCollection 2019. Review.

18.

The transformation of radiation oncology using real-time magnetic resonance guidance: A review.

Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, Bassetti MF, Robinson CG, Minsky BD, Choudhury A, Tersteeg RJHA, Schultz CJ; MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium.

Eur J Cancer. 2019 Nov;122:42-52. doi: 10.1016/j.ejca.2019.07.021. Epub 2019 Oct 12. Review.

PMID:
31614288
19.

Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy.

Ng SP, Pollard C 3rd, Kamal M, Ayoub Z, Garden AS, Bahig H, Gunn GB, Frank SJ, Skinner HD, Phan J, Berends J, Morrison WH, Johnson JM, Ferrarotto R, Sturgis EM, Mohamed ASR, Lai SY, Fuller CD, Rosenthal DI.

NPJ Precis Oncol. 2019 Sep 27;3:22. doi: 10.1038/s41698-019-0097-y. eCollection 2019.

20.

Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy.

Mesko S, Wang H, Tung S, Wang C, Pasalic D, Chapman BV, Moreno AC, Reddy JP, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Fuller CD, Morrison W, Phan J.

Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):185-193. doi: 10.1016/j.ijrobp.2019.09.010. Epub 2019 Sep 30.

PMID:
31580928
21.

Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer.

Hutcheson KA, Warneke CL, Yao CMKL, Zaveri J, Elgohari BE, Goepfert R, Hessel AC, Kupferman ME, Lai SY, Fuller CD, Gunn GB, Garden AS, Johnson F, Ferrarotto R, Lewin JS, Gross ND; MD Anderson Head and Neck Cancer Symptom Working Group.

JAMA Otolaryngol Head Neck Surg. 2019 Sep 26. doi: 10.1001/jamaoto.2019.2725. [Epub ahead of print]

PMID:
31556933
22.

Quantifying the accuracy of deformable image registration for cone-beam computed tomography with a physical phantom.

Wu RY, Liu AY, Williamson TD, Yang J, Wisdom PG, Zhu XR, Frank SJ, Fuller CD, Gunn GB, Gao S.

J Appl Clin Med Phys. 2019 Oct;20(10):92-100. doi: 10.1002/acm2.12717. Epub 2019 Sep 21.

23.

Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients.

Ger RB, Zhou S, Elgohari B, Elhalawani H, Mackin DM, Meier JG, Nguyen CM, Anderson BM, Gay C, Ning J, Fuller CD, Li H, Howell RM, Layman RR, Mawlawi O, Stafford RJ, Aerts H, Court LE.

PLoS One. 2019 Sep 19;14(9):e0222509. doi: 10.1371/journal.pone.0222509. eCollection 2019.

24.

Effects of alterations in positron emission tomography imaging parameters on radiomics features.

Ger RB, Meier JG, Pahlka RB, Gay S, Mumme R, Fuller CD, Li H, Howell RM, Layman RR, Stafford RJ, Zhou S, Mawlawi O, Court LE.

PLoS One. 2019 Sep 5;14(9):e0221877. doi: 10.1371/journal.pone.0221877. eCollection 2019.

25.

Cohort-based T-SSIM Visual Computing for Radiation Therapy Prediction and Exploration.

Wentzel A, Hanula P, Luciani T, Elgohari B, Elhalawani H, Canahuate G, Vock D, Fuller CD, Marai GE.

IEEE Trans Vis Comput Graph. 2020 Jan;26(1):949-959. doi: 10.1109/TVCG.2019.2934546. Epub 2019 Aug 22.

PMID:
31442988
26.

Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis.

Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Lai SY, Fuller CD, Lewin JS, Piller LB, Hutcheson KA.

Head Neck. 2019 Nov;41(11):3880-3894. doi: 10.1002/hed.25923. Epub 2019 Aug 23.

PMID:
31441572
27.

Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation.

Heukelom J, Kantor ME, Mohamed ASR, Elhalawani H, Kocak-Uzel E, Lin T, Yang J, Aristophanous M, Rasch CR, Fuller CD, Sonke JJ.

Radiother Oncol. 2020 Jan;142:100-106. doi: 10.1016/j.radonc.2019.07.034. Epub 2019 Aug 17.

PMID:
31431381
28.

Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy.

Bagley AF, Ye R, Garden AS, Gunn GB, Rosenthal DI, Fuller CD, Morrison WH, Phan J, Sturgis EM, Ferrarotto R, Wu R, Liu AY, Frank SJ.

Radiother Oncol. 2020 Jan;142:133-139. doi: 10.1016/j.radonc.2019.07.012. Epub 2019 Aug 17.

PMID:
31431373
29.

Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing.

Zaid M, Bajaj N, Burrows H, Mathew R, Dai A, Wilke CT, Palasi S, Hergenrother R, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS, Koay EJ.

Radiat Oncol. 2019 Aug 19;14(1):148. doi: 10.1186/s13014-019-1357-2.

30.

Sex-Based Disparities Among Cancer Clinical Trial Participants.

Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E.

J Natl Cancer Inst. 2020 Feb 1;112(2):211-213. doi: 10.1093/jnci/djz154.

PMID:
31350545
31.

Repetitive MRI of organs at risk in head and neck cancer patients undergoing radiotherapy.

Stieb S, Elgohari B, Fuller CD.

Clin Transl Radiat Oncol. 2019 Apr 26;18:131-139. doi: 10.1016/j.ctro.2019.04.014. eCollection 2019 Sep. Review.

32.

Prospective quantitative quality assurance and deformation estimation of MRI-CT image registration in simulation of head and neck radiotherapy patients.

Joint Head and Neck MRI-Radiotherapy Development Cooperative, Kiser K, Meheissen MAM, Mohamed ASR, Kamal M, Ng SP, Elhalawani H, Jethanandani A, He R, Ding Y, Rostom Y, Hegazy N, Bahig H, Garden A, Lai S, Phan J, Gunn GB, Rosenthal D, Frank S, Brock KK, Wang J, Fuller CD.

Clin Transl Radiat Oncol. 2019 Apr 24;18:120-127. doi: 10.1016/j.ctro.2019.04.018. eCollection 2019 Sep.

33.

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma.

Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME.

Thyroid. 2019 Aug;29(8):1036-1043. doi: 10.1089/thy.2019.0133.

34.

Biomechanical modeling of neck flexion for deformable alignment of the salivary glands in head and neck cancer images.

McCulloch MM, Anderson BM, Cazoulat G, Peterson CB, Mohamed ASR, Volpe S, Elhalawani H, Bahig H, Rigaud B, King JB, Ford AC, Fuller CD, Brock KK.

Phys Med Biol. 2019 Sep 5;64(17):175018. doi: 10.1088/1361-6560/ab2f13.

PMID:
31269475
35.

Assessing the Impact of Complementary and Alternative Medicine Trials in Oncology.

Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Grossberg AJ, Fuller CD.

Integr Cancer Ther. 2019 Jan-Dec;18:1534735419859089. doi: 10.1177/1534735419859089. No abstract available.

36.

The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology.

Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Verma V, VanderWalde NA, Grossberg AJ, Guadagnolo BA, Koong AC, Jagsi R, Thomas CR, Fuller CD.

J Natl Cancer Inst. 2019 Dec 1;111(12):1358-1360. doi: 10.1093/jnci/djz117.

PMID:
31165160
37.

Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.

Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, Gomez DR, Thomas CR Jr, Fuller CD.

JAMA Oncol. 2019 Jun 3. doi: 10.1001/jamaoncol.2019.2055. [Epub ahead of print]

PMID:
31158272
38.

Enhancing Career Paths for Tomorrow's Radiation Oncologists.

Vapiwala N, Thomas CR Jr, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD Jr, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CN.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):52-63. doi: 10.1016/j.ijrobp.2019.05.025. Epub 2019 May 22. Review. No abstract available.

PMID:
31128144
39.

Use of the g-index for assessment of citation-based scholarly activity of United States radiation oncology residents and subsequent choice of academic versus private practice career.

McClelland Iii S, Mitin T, Nabavizadeh N, Fuller CD, Thomas CR Jr, Jaboin JJ.

Rep Pract Oncol Radiother. 2019 May-Jun;24(3):294-297. doi: 10.1016/j.rpor.2019.03.005. Epub 2019 Apr 30.

PMID:
31080366
40.

Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial.

Gunn GB, Mendoza TR, Garden AS, Wang XS, Shi Q, Morrison WH, Frank SJ, Phan J, Fuller CD, Chambers MS, Hanna EY, Lu C, Rosenthal DI, Cleeland CS.

Support Care Cancer. 2020 Jan;28(1):261-269. doi: 10.1007/s00520-019-04791-4. Epub 2019 Apr 29.

PMID:
31037378
41.

Head and Neck Cancer Adaptive Radiation Therapy (ART): Conceptual Considerations for the Informed Clinician.

Heukelom J, Fuller CD.

Semin Radiat Oncol. 2019 Jul;29(3):258-273. doi: 10.1016/j.semradonc.2019.02.008. Review.

PMID:
31027643
42.

Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.

Nguyen QN, Chun SG, Chow E, Komaki R, Liao Z, Zacharia R, Szeto BK, Welsh JW, Hahn SM, Fuller CD, Moon BS, Bird JE, Satcher R, Lin PP, Jeter M, O'Reilly MS, Lewis VO.

JAMA Oncol. 2019 Jun 1;5(6):872-878. doi: 10.1001/jamaoncol.2019.0192.

PMID:
31021390
43.

Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.

Ho JC, Fang P, Cardenas CE, Mohamed ASR, Fuller CD, Allen PK, Bhosale PR, Frumovitz MM, Jhingran A, Klopp AH.

Radiother Oncol. 2019 Jun;135:58-64. doi: 10.1016/j.radonc.2019.02.012. Epub 2019 Mar 11.

PMID:
31015171
44.

The Potential and Pitfalls of Crowdsourced Algorithm Development in Radiation Oncology.

Elhalawani H, Fuller CD, Thompson RF.

JAMA Oncol. 2019 May 1;5(5):662-663. doi: 10.1001/jamaoncol.2019.0157. No abstract available.

PMID:
30998812
45.

Predictive Models to Determine Clinically Relevant Deviations in Delivered Dose for Head and Neck Cancer.

McCulloch MM, Lee C, Rosen BS, Kamp JD, Lockhart CM, Lee JY, Polan DF, Hawkins PG, Anderson CJR, Heukelom J, Sonke JJ, Fuller CD, Balter JM, Ten Haken RK, Eisbruch A, Brock KK.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):e422-e431. doi: 10.1016/j.prro.2019.02.014. Epub 2019 Mar 2.

PMID:
30836190
46.

Career Enrichment Opportunities at the Scientific Frontier in Radiation Oncology.

Thompson RF, Fuller CD, Berman AT, Aneja S, Thomas CR Jr.

JCO Clin Cancer Inform. 2019 Feb;3:1-4. doi: 10.1200/CCI.18.00126. No abstract available.

47.

An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting.

Elhalawani H, Elgohari B, Lin TA, Mohamed ASR, Fitzgerald TJ, Laurie F, Ulin K, Kalpathy-Cramer J, Guerrero T, Holliday EB, Russo G, Patel A, Jones W, Walker GV, Awan M, Choi M, Dagan R, Mahmoud O, Shapiro A, Kong FS, Gomez D, Zeng J, Decker R, Spoelstra FOB, Gaspar LE, Kachnic LA, Thomas CR Jr, Okunieff P, Fuller CD.

Clin Transl Radiat Oncol. 2019 Jan 6;15:83-92. doi: 10.1016/j.ctro.2019.01.001. eCollection 2019 Feb.

48.

Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.

Mohamed ASR, Smith BD, Smith JB, Sevak P, Malek JS, Kanwar A, Browne T, Gunn GB, Garden AS, Frank SJ, Morrison WH, Phan J, Zafereo M, Skinner H, Lai SY, Hutcheson KA, Lewin JS, Hessel AE, Thekdi AA, Weber RS, Fuller CD, Rosenthal DI.

Laryngoscope. 2020 Jan;130(1):146-153. doi: 10.1002/lary.27873. Epub 2019 Feb 12.

PMID:
30756394
49.

Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.

Ng SP, Pollard C 3rd, Berends J, Ayoub Z, Kamal M, Garden AS, Bahig H, Cantor SB, Schaefer AJ, Ajayi T, Gunn GB, Frank SJ, Skinner H, Phan J, Morrison WH, Ferrarotto R, Johnson JM, Mohamed ASR, Lai SY, Hessel AC, Sturgis EM, Weber RS, Fuller CD, Rosenthal DI.

Cancer. 2019 Jun 1;125(11):1823-1829. doi: 10.1002/cncr.31983. Epub 2019 Feb 12.

PMID:
30748005
50.

Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.

Zhu Y, Mohamed ASR, Lai SY, Yang S, Kanwar A, Wei L, Kamal M, Sengupta S, Elhalawani H, Skinner H, Mackin DS, Shiao J, Messer J, Wong A, Ding Y, Zhang L, Court L, Ji Y, Fuller CD.

JCO Clin Cancer Inform. 2019 Feb;3:1-9. doi: 10.1200/CCI.18.00073.

Supplemental Content

Loading ...
Support Center